PDB4 HbA1C Reduction Associated With Initial Versus Sequential Combination Therapy With Pioglitazone (PIO) and Dipeptidyl Peptidase-4 Inhibitors (DPP4i) in Patients With Type 2 Diabetes Mellitus (T2DM)
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1647
https://www.valueinhealthjournal.com/article/S1098-3015(12)03360-8/fulltext
Title :
PDB4 HbA1C Reduction Associated With Initial Versus Sequential Combination Therapy With Pioglitazone (PIO) and Dipeptidyl Peptidase-4 Inhibitors (DPP4i) in Patients With Type 2 Diabetes Mellitus (T2DM)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03360-8&doi=10.1016/j.jval.2012.08.1647
First page :
A493
Section Title :
Diabetes/Endocrine Disorders
Open access? :
No
Section Order :
1139